Jacob Kress, Sookyeong Kim, Caitlynn Bryant, Emily Camila Lopez-Lopez, Jiali Zha, Mathew Tantama
{"title":"mSumireF a Monomeric Violet Fluorescent Protein","authors":"Jacob Kress, Sookyeong Kim, Caitlynn Bryant, Emily Camila Lopez-Lopez, Jiali Zha, Mathew Tantama","doi":"10.1021/acsbiomedchemau.5c00175","DOIUrl":null,"url":null,"abstract":"<p>The development of\r\ngenetically encoded labels for multicolor experiments\r\nrequires a diverse palette of fluorescent proteins that are well-behaved.\r\nHere, we report mSumireF, a monomeric variant of the violet fluorescent\r\nprotein Sumire. On its own, the canonical monomerizing valine-to-lysine\r\nmutation at residue 206 causes a significant loss of brightness for\r\nthe mSumire variant. We found that brightness is recovered upon the\r\nreversion of mSumire’s tyrosine at position 165 back to phenylalanine\r\nas in its superfolder GFP grandparent. Importantly, this mSumireF\r\nvariant exhibits significantly less oligomerization tendency in the\r\norganized smooth endoplasmic reticulum (OSER) assay in mammalian cells\r\nand in protein solution assays. Furthermore, we demonstrate that an\r\nmSumireF donor can be effectively paired with the fluorescent protein\r\nacceptors mCerulean3, mTurquoise2, and LSSmScarlet to generate FRET-based\r\nATP biosensors. mSumireF thus provides an improved violet fluorescent\r\nprotein to expand color options with reduced concern of unwanted dimerization.</p>","PeriodicalId":29802,"journal":{"name":"ACS Bio & Med Chem Au","volume":"6 1","pages":"36–43"},"PeriodicalIF":3.5000,"publicationDate":"2026-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Bio & Med Chem Au","FirstCategoryId":"1085","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acsbiomedchemau.5c00175","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/6 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The development of
genetically encoded labels for multicolor experiments
requires a diverse palette of fluorescent proteins that are well-behaved.
Here, we report mSumireF, a monomeric variant of the violet fluorescent
protein Sumire. On its own, the canonical monomerizing valine-to-lysine
mutation at residue 206 causes a significant loss of brightness for
the mSumire variant. We found that brightness is recovered upon the
reversion of mSumire’s tyrosine at position 165 back to phenylalanine
as in its superfolder GFP grandparent. Importantly, this mSumireF
variant exhibits significantly less oligomerization tendency in the
organized smooth endoplasmic reticulum (OSER) assay in mammalian cells
and in protein solution assays. Furthermore, we demonstrate that an
mSumireF donor can be effectively paired with the fluorescent protein
acceptors mCerulean3, mTurquoise2, and LSSmScarlet to generate FRET-based
ATP biosensors. mSumireF thus provides an improved violet fluorescent
protein to expand color options with reduced concern of unwanted dimerization.
期刊介绍:
ACS Bio & Med Chem Au is a broad scope open access journal which publishes short letters comprehensive articles reviews and perspectives in all aspects of biological and medicinal chemistry. Studies providing fundamental insights or describing novel syntheses as well as clinical or other applications-based work are welcomed.This broad scope includes experimental and theoretical studies on the chemical physical mechanistic and/or structural basis of biological or cell function in all domains of life. It encompasses the fields of chemical biology synthetic biology disease biology cell biology agriculture and food natural products research nucleic acid biology neuroscience structural biology and biophysics.The journal publishes studies that pertain to a broad range of medicinal chemistry including compound design and optimization biological evaluation molecular mechanistic understanding of drug delivery and drug delivery systems imaging agents and pharmacology and translational science of both small and large bioactive molecules. Novel computational cheminformatics and structural studies for the identification (or structure-activity relationship analysis) of bioactive molecules ligands and their targets are also welcome. The journal will consider computational studies applying established computational methods but only in combination with novel and original experimental data (e.g. in cases where new compounds have been designed and tested).Also included in the scope of the journal are articles relating to infectious diseases research on pathogens host-pathogen interactions therapeutics diagnostics vaccines drug-delivery systems and other biomedical technology development pertaining to infectious diseases.